Eurazeo’s Small-Mid Buyout team is to sell in majority stake in Intech, a global market leader in the manufacturing and development of orthopaedic surgical instruments, to Montagu Private Equity. The proposed sale is subject to US competition authority approval.
Since its investment in 2017, Eurazeo has supported Intech by providing the human and financial resources needed for its development, thus helping to more than double the company’s business in just four years, to over EUR 120 million in 2021. During this period, Intech has reinforced its leadership position in spinal surgery instrument and implants while becoming one of the pioneers in the rapidly growing robotics market thanks to its R&D and prototyping capabilities, thereby gaining a strong competitive advantage.
With the successful acquisition and integration of Pyxidis in France in 2017 and of Bradshaw in the United States in 2018, Intech has been able to broaden its product range and strengthen its presence in the world-leading US market, where the company now generates more than 75% of its revenue. Intech has also invested in its manufacturing facilities, upgrading and expanding several plants, but also rethinking its processes to boost efficiency in order to better serve its international customers.
Lastly, based on the shared strategic vision of Intech’s management and Eurazeo’s Small-Mid Buyout team, the company has been able to bolster its model around its core values of innovation, quality, customer-centric approach, and responsible development.
With this deal, Eurazeo is set to achieve a cash-on-cash multiple of 3.0x and an IRR of 31%.
Laurent Pruvost, President and CEO of Intech, says: “Intech’s entire management team and all the Intechers join me in thanking Eurazeo for the quality of the partnership we have built up over these last four years. Eurazeo’s teams have been firmly at our side at key moments in this chapter of our story. By offering advice or operational support in connection with our latest transformative acquisitions or by reviewing and approving major investment decisions, Eurazeo has helped us consolidate our strategic position in a fast-changing market. Today, we are stronger than ever before to continue meeting the needs of our customers.”
Source: Private Equity Wire